Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:645967.
doi: 10.1155/2012/645967. Epub 2012 Mar 5.

Neurological Disorders in Primary Sjögren's Syndrome

Gabriel J Tobón  1 , Jacques-Olivier Pers, Valérie Devauchelle-Pensec, Pierre Youinou
Affiliations

Neurological Disorders in Primary Sjögren's Syndrome

Gabriel J Tobón et al. Autoimmune Dis. 2012.

Abstract

Sjögren's syndrome is an autoimmune disease characterized by an autoimmune exocrinopathy involving mainly salivary and lacrimal glands. The histopathological hallmark is periductal lymphocytic infiltration of the exocrine glands, resulting in loss of their secretory function. Several systemic manifestations may be found in patients with Sjögren's syndrome including neurological disorders. Neurological involvement ranges from 0 to 70% among various series and may present with central nervous system and/or peripheral nervous system involvement. This paper endeavors to review the main clinical neurological manifestations in Sjögren syndrome, the physiopathology, and their therapeutic response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathophysiological mechanism implicated in the development of central and peripheral nervous system manifestations in primary Sjögren's syndrome.
See this image and copyright information in PMC

References

    1. Moutsopoulos HM. Sjögren’s syndrome: autoimmune epithelitis. Clinical Immunology and Immunopathology. 1994;72(2):162–165. - PubMed
    1. Sheldon J. Laboratory testing in autoimmune rheumatic diseases. Best Practice and Research. 2004;18(3):249–269. - PubMed
    1. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjögren’s syndrome. Arthritis and Rheumatism. 1999;42(8):1765–1772. - PubMed
    1. Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren’s syndrome: where are we now? Clinical and Experimental Rheumatology. 2007;25(1):1–4. - PubMed
    1. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Clasification criteria for Sjögren’s syndrome. A revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases. 2002;61(6):554–558. - PMC - PubMed

LinkOut - more resources